Report Detail

Request for Sample of this report

Pharma & Healthcare Global mRNA Vaccines for Animals Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4734137
    • |
  • 24 August, 2026
    • |
  • Global
    • |
  • 103 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global mRNA Vaccines for Animals market size was valued at US$ 148 million in 2025 and is forecast to a readjusted size of US$ 3799 million by 2032 with a CAGR of 59.7% during review period.
mRNA vaccines for animals are a type of veterinary vaccine that use messenger RNA (mRNA) technology to stimulate an immune response against specific pathogens in livestock, pets, and other animals. These vaccines work by delivering synthetic mRNA encoding viral or bacterial antigens into the animal’s cells, prompting the immune system to recognize and fight the targeted disease. Compared to traditional vaccines, mRNA vaccines offer faster development timelines, improved efficacy, and the ability to rapidly adapt to emerging animal diseases. They are being explored for various applications, including livestock diseases (such as foot-and-mouth disease), zoonotic infections, and companion animal health.
Market Development Opportunities & Main Driving Factors
mRNA vaccines for animals, as a new generation of biological products, are reshaping the global veterinary vaccine landscape with their rapid development, high specificity, and scalability. According to annual reports from animal health companies and brokerage research, the demand for epidemic prevention in the livestock industry continues to rise, particularly against transboundary infectious diseases and major animal epidemics, which accelerates investment in novel vaccines. The proven success of mRNA technology in human COVID-19 vaccines validates its potential in veterinary applications. Coupled with strong policy support for food safety, livestock modernization, and public health, the market expansion potential for animal mRNA vaccines is significant.
Market Challenges, Risks, & Restraints
Despite promising prospects, animal mRNA vaccines face multiple challenges. Their storage, transportation, and mass production require stringent cold chain and advanced equipment, leading to higher costs compared to traditional vaccines. Regulatory frameworks remain immature, with varying standards for registration and safety validation across regions, adding uncertainty to commercialization. Additionally, the industry is dominated by multinational animal health giants with strong technological and financial advantages, creating barriers for smaller firms facing fierce competition and potential technological hurdles.
Downstream Demand Trends
As livestock farming becomes increasingly large-scale and intensive, and as consumer awareness of food safety and animal health grows, demand for safe and effective novel vaccines continues to rise. In particular, poultry, swine, and companion animal sectors exhibit strong demand for rapid-response vaccines against emerging diseases. Growing government investment in animal disease prevention and farmers’ need to reduce losses and improve efficiency will further drive adoption. In the long term, animal mRNA vaccines are poised to become a critical technology supporting livestock stability and food supply security.
This report is a detailed and comprehensive analysis for global mRNA Vaccines for Animals market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global mRNA Vaccines for Animals market size and forecasts, in consumption value ($ Million), 2021-2032
Global mRNA Vaccines for Animals market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global mRNA Vaccines for Animals market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global mRNA Vaccines for Animals market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Vaccines for Animals
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Vaccines for Animals market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ceva Animal Health, Merck Animal Health, Areterna, Bayer, BioNTech, Genvax Technologies, BioVenic, Moderna, Ruipu Biotechnology, Jinyu Bio-technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
mRNA Vaccines for Animals market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Non-replicating mRNA vaccines
Self-replicating mRNA vaccines
Market segment by Application
Pigs
Poultry
Companion Animals
Ruminants
Market segment by players, this report covers
Ceva Animal Health
Merck Animal Health
Areterna
Bayer
BioNTech
Genvax Technologies
BioVenic
Moderna
Ruipu Biotechnology
Jinyu Bio-technology
Shanghai Shen Lian Biomedical
Suzhou Kerui Meide Biomedical Technology
Shanghai Rnacure Biopharma
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe mRNA Vaccines for Animals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of mRNA Vaccines for Animals, with revenue, gross margin, and global market share of mRNA Vaccines for Animals from 2021 to 2026.
Chapter 3, the mRNA Vaccines for Animals competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and mRNA Vaccines for Animals market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Vaccines for Animals.
Chapter 13, to describe mRNA Vaccines for Animals research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of mRNA Vaccines for Animals by Type
    • 1.3.1 Overview: Global mRNA Vaccines for Animals Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global mRNA Vaccines for Animals Consumption Value Market Share by Type in 2025
    • 1.3.3 Non-replicating mRNA vaccines
    • 1.3.4 Self-replicating mRNA vaccines
  • 1.4 Global mRNA Vaccines for Animals Market by Application
    • 1.4.1 Overview: Global mRNA Vaccines for Animals Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pigs
    • 1.4.3 Poultry
    • 1.4.4 Companion Animals
    • 1.4.5 Ruminants
  • 1.5 Global mRNA Vaccines for Animals Market Size & Forecast
  • 1.6 Global mRNA Vaccines for Animals Market Size and Forecast by Region
    • 1.6.1 Global mRNA Vaccines for Animals Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global mRNA Vaccines for Animals Market Size by Region, (2021-2032)
    • 1.6.3 North America mRNA Vaccines for Animals Market Size and Prospect (2021-2032)
    • 1.6.4 Europe mRNA Vaccines for Animals Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific mRNA Vaccines for Animals Market Size and Prospect (2021-2032)
    • 1.6.6 South America mRNA Vaccines for Animals Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa mRNA Vaccines for Animals Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Ceva Animal Health
    • 2.1.1 Ceva Animal Health Details
    • 2.1.2 Ceva Animal Health Major Business
    • 2.1.3 Ceva Animal Health mRNA Vaccines for Animals Product and Solutions
    • 2.1.4 Ceva Animal Health mRNA Vaccines for Animals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Ceva Animal Health Recent Developments and Future Plans
  • 2.2 Merck Animal Health
    • 2.2.1 Merck Animal Health Details
    • 2.2.2 Merck Animal Health Major Business
    • 2.2.3 Merck Animal Health mRNA Vaccines for Animals Product and Solutions
    • 2.2.4 Merck Animal Health mRNA Vaccines for Animals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Merck Animal Health Recent Developments and Future Plans
  • 2.3 Areterna
    • 2.3.1 Areterna Details
    • 2.3.2 Areterna Major Business
    • 2.3.3 Areterna mRNA Vaccines for Animals Product and Solutions
    • 2.3.4 Areterna mRNA Vaccines for Animals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Areterna Recent Developments and Future Plans
  • 2.4 Bayer
    • 2.4.1 Bayer Details
    • 2.4.2 Bayer Major Business
    • 2.4.3 Bayer mRNA Vaccines for Animals Product and Solutions
    • 2.4.4 Bayer mRNA Vaccines for Animals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Bayer Recent Developments and Future Plans
  • 2.5 BioNTech
    • 2.5.1 BioNTech Details
    • 2.5.2 BioNTech Major Business
    • 2.5.3 BioNTech mRNA Vaccines for Animals Product and Solutions
    • 2.5.4 BioNTech mRNA Vaccines for Animals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 BioNTech Recent Developments and Future Plans
  • 2.6 Genvax Technologies
    • 2.6.1 Genvax Technologies Details
    • 2.6.2 Genvax Technologies Major Business
    • 2.6.3 Genvax Technologies mRNA Vaccines for Animals Product and Solutions
    • 2.6.4 Genvax Technologies mRNA Vaccines for Animals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Genvax Technologies Recent Developments and Future Plans
  • 2.7 BioVenic
    • 2.7.1 BioVenic Details
    • 2.7.2 BioVenic Major Business
    • 2.7.3 BioVenic mRNA Vaccines for Animals Product and Solutions
    • 2.7.4 BioVenic mRNA Vaccines for Animals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 BioVenic Recent Developments and Future Plans
  • 2.8 Moderna
    • 2.8.1 Moderna Details
    • 2.8.2 Moderna Major Business
    • 2.8.3 Moderna mRNA Vaccines for Animals Product and Solutions
    • 2.8.4 Moderna mRNA Vaccines for Animals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Moderna Recent Developments and Future Plans
  • 2.9 Ruipu Biotechnology
    • 2.9.1 Ruipu Biotechnology Details
    • 2.9.2 Ruipu Biotechnology Major Business
    • 2.9.3 Ruipu Biotechnology mRNA Vaccines for Animals Product and Solutions
    • 2.9.4 Ruipu Biotechnology mRNA Vaccines for Animals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Ruipu Biotechnology Recent Developments and Future Plans
  • 2.10 Jinyu Bio-technology
    • 2.10.1 Jinyu Bio-technology Details
    • 2.10.2 Jinyu Bio-technology Major Business
    • 2.10.3 Jinyu Bio-technology mRNA Vaccines for Animals Product and Solutions
    • 2.10.4 Jinyu Bio-technology mRNA Vaccines for Animals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Jinyu Bio-technology Recent Developments and Future Plans
  • 2.11 Shanghai Shen Lian Biomedical
    • 2.11.1 Shanghai Shen Lian Biomedical Details
    • 2.11.2 Shanghai Shen Lian Biomedical Major Business
    • 2.11.3 Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Product and Solutions
    • 2.11.4 Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Shanghai Shen Lian Biomedical Recent Developments and Future Plans
  • 2.12 Suzhou Kerui Meide Biomedical Technology
    • 2.12.1 Suzhou Kerui Meide Biomedical Technology Details
    • 2.12.2 Suzhou Kerui Meide Biomedical Technology Major Business
    • 2.12.3 Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Product and Solutions
    • 2.12.4 Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Suzhou Kerui Meide Biomedical Technology Recent Developments and Future Plans
  • 2.13 Shanghai Rnacure Biopharma
    • 2.13.1 Shanghai Rnacure Biopharma Details
    • 2.13.2 Shanghai Rnacure Biopharma Major Business
    • 2.13.3 Shanghai Rnacure Biopharma mRNA Vaccines for Animals Product and Solutions
    • 2.13.4 Shanghai Rnacure Biopharma mRNA Vaccines for Animals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Shanghai Rnacure Biopharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global mRNA Vaccines for Animals Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of mRNA Vaccines for Animals by Company Revenue
    • 3.2.2 Top 3 mRNA Vaccines for Animals Players Market Share in 2025
    • 3.2.3 Top 6 mRNA Vaccines for Animals Players Market Share in 2025
  • 3.3 mRNA Vaccines for Animals Market: Overall Company Footprint Analysis
    • 3.3.1 mRNA Vaccines for Animals Market: Region Footprint
    • 3.3.2 mRNA Vaccines for Animals Market: Company Product Type Footprint
    • 3.3.3 mRNA Vaccines for Animals Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global mRNA Vaccines for Animals Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global mRNA Vaccines for Animals Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global mRNA Vaccines for Animals Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global mRNA Vaccines for Animals Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America mRNA Vaccines for Animals Consumption Value by Type (2021-2032)
  • 6.2 North America mRNA Vaccines for Animals Market Size by Application (2021-2032)
  • 6.3 North America mRNA Vaccines for Animals Market Size by Country
    • 6.3.1 North America mRNA Vaccines for Animals Consumption Value by Country (2021-2032)
    • 6.3.2 United States mRNA Vaccines for Animals Market Size and Forecast (2021-2032)
    • 6.3.3 Canada mRNA Vaccines for Animals Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico mRNA Vaccines for Animals Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe mRNA Vaccines for Animals Consumption Value by Type (2021-2032)
  • 7.2 Europe mRNA Vaccines for Animals Consumption Value by Application (2021-2032)
  • 7.3 Europe mRNA Vaccines for Animals Market Size by Country
    • 7.3.1 Europe mRNA Vaccines for Animals Consumption Value by Country (2021-2032)
    • 7.3.2 Germany mRNA Vaccines for Animals Market Size and Forecast (2021-2032)
    • 7.3.3 France mRNA Vaccines for Animals Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom mRNA Vaccines for Animals Market Size and Forecast (2021-2032)
    • 7.3.5 Russia mRNA Vaccines for Animals Market Size and Forecast (2021-2032)
    • 7.3.6 Italy mRNA Vaccines for Animals Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific mRNA Vaccines for Animals Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific mRNA Vaccines for Animals Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific mRNA Vaccines for Animals Market Size by Region
    • 8.3.1 Asia-Pacific mRNA Vaccines for Animals Consumption Value by Region (2021-2032)
    • 8.3.2 China mRNA Vaccines for Animals Market Size and Forecast (2021-2032)
    • 8.3.3 Japan mRNA Vaccines for Animals Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea mRNA Vaccines for Animals Market Size and Forecast (2021-2032)
    • 8.3.5 India mRNA Vaccines for Animals Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia mRNA Vaccines for Animals Market Size and Forecast (2021-2032)
    • 8.3.7 Australia mRNA Vaccines for Animals Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America mRNA Vaccines for Animals Consumption Value by Type (2021-2032)
  • 9.2 South America mRNA Vaccines for Animals Consumption Value by Application (2021-2032)
  • 9.3 South America mRNA Vaccines for Animals Market Size by Country
    • 9.3.1 South America mRNA Vaccines for Animals Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil mRNA Vaccines for Animals Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina mRNA Vaccines for Animals Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa mRNA Vaccines for Animals Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa mRNA Vaccines for Animals Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa mRNA Vaccines for Animals Market Size by Country
    • 10.3.1 Middle East & Africa mRNA Vaccines for Animals Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey mRNA Vaccines for Animals Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia mRNA Vaccines for Animals Market Size and Forecast (2021-2032)
    • 10.3.4 UAE mRNA Vaccines for Animals Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 mRNA Vaccines for Animals Market Drivers
  • 11.2 mRNA Vaccines for Animals Market Restraints
  • 11.3 mRNA Vaccines for Animals Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 mRNA Vaccines for Animals Industry Chain
  • 12.2 mRNA Vaccines for Animals Upstream Analysis
  • 12.3 mRNA Vaccines for Animals Midstream Analysis
  • 12.4 mRNA Vaccines for Animals Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on mRNA Vaccines for Animals. Industry analysis & Market Report on mRNA Vaccines for Animals is a syndicated market report, published as Global mRNA Vaccines for Animals Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of mRNA Vaccines for Animals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo